DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Wednesday reported a fiscal first-quarter loss of $26.5 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Danvers, Massachusetts-based company said it had a loss of 59 cents. Earnings, adjusted for one-time gains and costs, were $1.10 per share.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.06 per share.

The maker of heart devices posted revenue of $252.6 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $243.8 million.

Abiomed expects full-year revenue in the range of $1.03 billion to $1.05 billion.

Abiomed shares have risen 2% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $331.20, an increase of 8.5% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABMD at https://www.zacks.com/ap/ABMD

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News